- Citado por SciELO
versión impresa ISSN 0103-5053
J. Braz. Chem. Soc. v.18 n.4 São Paulo 2007
Hélio Corrêa de MeloI; Ana Paula D. SeleghimII; Wagner Luiz PolitoII; Orlando Fatibello-FilhoIII, *; Iolanda C. VieiraIV
IDepartamento de Química, Universidade Federal de Ouro Preto, 35400-000 Ouro Preto-MG, Brazil
IIInstituto de Química de São Carlos, Universidade de São Paulo, 13566-590 São Carlos- SP, Brazil
IIIDepartamento de Química, Centro de Ciências Exatas e de Tecnologia, Universidade Federal de São Carlos, CP 676, 13560-970 São Carlos-SP, Brazil
IVDepartamento de Química, Universidade Federal de Santa Catarina, 88040-970 Florianópolis-SC, Brazil
A carbon paste electrode modified with lead dioxide immobilized in a polyester resin has been developed for simultaneous differential pulse voltammetric determination of L-dopa and carbidopa in pharmaceutical formulations. The analytical curves were linear in the concentration ranges from 2.6 ´ 10-4 to 1.2 ´ 10-3 mol L-1 and from 3.2 ´ 10-5 to 1.5 ´ 10-4 mol L-1 for L-dopa and carbidopa, respectively. The detection limits were 2.5 ´ 10-5 mol L-1 and 3.7 ´ 10-6 mol L-1 for L-dopa and carbidopa, respectively and recoveries of L-dopa and carbidopa from two samples ranged from 98.1 to 103% of the added amount. The relative standard deviations were lower than 2.5% for 1.2 ´ 10-4 and 1.2 ´ 10-3 mol L-1 of these catecholamines solutions and the results obtained for L-dopa and carbidopa in pharmaceutical formulations using the proposed voltammetric procedure are in close agreement with the labeled values and/or those obtained using an enzymatic method at the 95% confidence level.
Keywords: L-dopa, carbidopa, differential pulse voltammetry (DPV), carbon paste electrode modified with lead dioxide
Um eletrodo de pasta de carbono modificado com dióxido de chumbo imobilizado em uma resina de poliéster foi desenvolvido para a determinação voltamétrica de pulso diferencial simultânea de L-dopa e carbidopa em formulações farmacêuticas. As curvas analíticas foram lineares em uma faixa de concentração de 2,6 ´ 10-4 a 1,2 ´ 10-3 mol L-1 e de 3,2 ´ 10-5 a 1,5 ´ 10-4 mol L-1 para L-dopa e carbidopa, respectivamente. Os limites de detecção foram 2,5 ´ 10-5 mol L-1 e 3,7 ´ 10-6 mol L-1 para L-dopa e carbidopa, respectivamente e as recuperações de L-dopa e carbidopa em duas amostras variaram de 98,1 a 103%. Os desvios padrão relativos foram menores que 2,5% para soluções 1,2 ´ 10-4 e 1,2 ´ 10-3 mol L-1 dessas catecolaminas e os resultados obtidos para L-dopa e carbidopa em formulações farmacêuticas usando o procedimento voltamétrico proposto estão em boa concordância com os valores rotulados ou com aqueles teores determinados empregando-se um procedimento enzimático a um nível de confiança de 95%.
L-dopa [(-)-3-(3,4-dihydroxyphenyl)-L-alanine] and carbidopa [(-)-L-2-(3,4-dihydroxybenzyl)-2-hydrazinopropionic acid] are catecholamines with an alkylamine chain attached to a benzene ring bearing two hydroxyl groups. They are used in several pharmaceutical formulations on association or each one alone for neural disorders compensations related to Parkinson's syndrome.1 Recently, experimental evidences show this disease as a consequence of some causes disturbing the production of the neurotransmitter dopamine. L-dopa is the immediate precursor of dopamine in the brain tissues. Nevertheless, L-dopa prescript as an active pure substance is ineffective itself on Parkinson's disease, since, in extra cerebral tissues, L-dopa is metabolized to dopamine and then to other metabolites, by a decarboxylation process. So, only a small fraction of unreacted carboxilated species, from a certain dosage of L-dopa, is transported across the cerebral tissues to the central nervous system. When carbidopa is used as inhibitor for the decarboxylase activity, with the concomitant use of carbidopa and L-dopa in pharmaceutical products, then a stronger concentration of the active catecholamine, i.e. L-dopa results.2 Hence, the development of a method for the simultaneous determination of L-dopa and carbidopa is very important, since they are frequently found together in some pharmaceutical formulations.
Several methods have been proposed for the simultaneous determination of these catecholamine drugs in biological specimens and/or pharmaceutical formulations. The determination of catecholamines in biological fluids normally requires the use of trace analysis techniques, mainly chromatography with fluorimetric or electrochemical detection.3 On the other hand, catecholamines are present in relatively large amounts in pharmaceutical formulations and much effort has been devoted to the development of simple, rapid, accurate and precise analytical methods. Of those, the most employed methods include spectrophotometry,4-6 high performance liquid chromatography (HPLC) with electrochemical detection7-15 and capillary zone electrophoresis (CZE) with electrochemical detection.16-20 To the best of our knowledge, there is only one differential pulse voltammetry (DPV) procedure in the literature using a glassy carbon electrode for the determination of L-dopa and a glassy carbon electrode coated with Nafion film for the determination of carbidopa.21
DPV has been demonstrated to be a useful technique for the determination of many molecules of biological importance.22 The high selectivity, sensitivity, accuracy, precision, simplicity and the possibility of analysis without tedious sample pre-treatment are the greatest advantage of this technique.
In this paper the development and the application of a novel carbon paste electrode modified with lead dioxide immobilized in polyester resin for simultaneous differential pulse voltammetric determination of L-dopa and carbidopa in pharmaceuticals were presented. Catecholamines can be oxidized on classical electrodes such as C, Pt and Au. However, phenols and/or cathecolamines can cause anode inactivation by oligomer deposition on such electrode surfaces.23-25 For this reason, lead dioxide was used to oxidize catecholamines in aqueous acid solution where the reaction is very fast. On the other hand, PbO2 has attracted considerable attention owing to its low price compared to noble metals, its chemical stability in corrosive media, and high value of the overpotential for oxygen evolution reaction.23 Also, this oxide had been used as electrode in batteries, wastewater treatment, ozone generation, electrosynthesis24 and in pH electrode26 with very good performance.
Cyclic-voltammetric and differential pulse voltammetric studies were performed with an EG & G-PAR, Model 273A Potentiostat/Galvanostat (Princeton, NJ, USA). This system was controlled by mean of an interface connected to a PC microcomputer 486 DX4-120MHZ and the software M270 EG & G PAR.
All electrochemical experiments were carried out in a 20 mL thermostated glass cell at 25 °C. A three-electrode assembly incorporating carbon paste electrode modified with lead dioxide as working electrode, an Ag/AgCl (sat. NaCl) reference and platinum wire auxiliary electrodes were used in all measurements.
Reagents and solutions
All reagents were of analytical grade and all solutions were prepared with water from a Millipore (Bedford, MA, USA) Milli-Q system (model UV Plus Ultra-Low Organics Water).
L-dopa was purchased from BDH (Poole, Dorset, UK) and carbidopa was kindly provided by Prodome Chemical and Pharmaceutical (Campinas, SP, Brazil). Stock solutions (1.0 ´ 10-2 mol L-1) were prepared daily in several supporting electrolytes (0.2 mol L-1 phosphate buffer solutions at pH ranging from 2 to 7, perchloric, sulfuric and phosphoric acids at concentrations varying from 0.05 to 0.5 mol L-1). Reference solutions from 2.0 ´ 10-5 to 2.0 ´ 10-3 mol L-1 were prepared from the stock solutions of the supporting electrolytes.
Carbon paste electrodes were prepared using solid paraffin (Sigma) and graphite powder (grade # 38) from Fisher.
L-dopa and carbidopa were determined in solid pharmaceuticals acquired in local drugstores such as Prolopa® (Roche Chemical and Pharmaceutical Products of São Paulo, SP, Brazil) and Sinemet® (Prodome Chemical and Pharmaceutical Ltda, Campinas, SP, Brazil).
Immobilization of PbO2
The immobilization of lead dioxide on the polyester resin was similar to that reported by Pereira and Fatibello-Filho.27 A mass of 10 g of polyester resin solution was transferred to a silicone rubber flask; then 10 g of PbO2 were added and after manual homogenization, 0.5 mL of methylethylketone (catalyst) were added and stirred until an increase of viscosity. After 3-4 h, a rigid solid was obtained, which was broken with a hammer and a coffee grinder was used to obtain small particles. The particle size was selected by passing them through known mesh sieves and particles equal and/or smaller than 100 mm were selected for the modified carbon paste electrodes construction.
Carbon paste electrodes preparation
The carbon paste electrode (CPE) was prepared manually by melting 0.125 g of the hydrophobic diluent (solid paraffin) (25% m/m) in a mortar thermostatically controlled in a water bath at temperature close to its melting point (54-56 °C). Subsequently, 0.375 g of graphite powder (75% m/m) were added and mixed for 15 min with a glass spatula to obtain a homogeneous paste.
For carbon paste electrode modified with lead dioxide (MCPE) the following mass percentage ratios (% m/m): (a) 65% of graphite, 25% of diluent and 10% of PbO2 immobilized in polyester; (b) 55% of graphite, 25% of diluent and 20% of PbO2 immobilized in polyester; (c) 45% of graphite, 25% of diluent and 30% of PbO2 immobilized in polyester and (d) 25% of graphite, 25% of diluent and 50% of PbO2 immobilized in polyester were employed.
For CPE and MCPE a portion of each paste (about 0.170 g) was packed into the tip of a 1 mL insulin plastic syringe (9 cm high and 0.3 cm internal diameter; geometrical area of 0.070 cm2) and a silver wire was inserted to obtain the external electric contact as describe elsewhere.28
Procedure and determination of L-dopa and carbidopa in pharmaceuticals
All measurements were made in a thermostated glass cell at 25.0 ± 0.2 °C in several supporting electrolyte.
The contents of 12 solid tablets were ground to a fine powder using a mortar and pestle. An accurately weighed amount of the resulting powder of 25-100 mg was transferred to a 100 mL beaker containing the 25 mL of supporting electrolyte and submitted to an ultra-sound bath for 10 min. After this, the suspension was passed through a Whatman # 1 filter paper and the filtered solution was collected in a 100 mL calibrated flask and the volume was made up with the same supporting electrolyte. Then, appropriate dilutions were made and voltammetric measurements were carried out at 25.0 + 0.2 °C.
Results and Discussion
Cyclic voltammetry studies
Initially, the electrochemical behavior of L-dopa and carbidopa on the MCPE was investigated by cyclic voltammetry in the following supporting electrolyte (0.2 mol L-1 phosphate buffer solutions at pH ranging from 2 to 7, perchloric, sulfuric and phosphoric acids at concentrations varying from 0.05 to 0.5 mol L-1. In this study, the potential was scanning between 100 and +1100 mV at a scan rate of 50 mV s-1. Of those supporting electrolyte solutions investigated better cyclic voltammogram shapes and peak separations were obtained using 0.1 mol L-1 perchloric acid solution at MCPE containing 20% m/m PbO2 in the carbon paste. In this supporting electrolyte solution no peak was observed in this potential range studied as can be seen in Figure 1 B (a). After addition of L-dopa (Figure 1 A; 5.0 ´ 10-4 mol L-1 L-dopa) or carbidopa to the blank (Figure 1 B; 3.0 ´ 10-4 carbidopa) the same anodic peaks for both of them were observed at a peak potential of 677 mV. In the case of carbidopa a second anodic peak was observed at a potential of 1050 mV. The peaks obtained at potentials 677 mV could be attributed to the electrochemical reaction of the two hydroxyls of L-dopa and carbidopa. The cyclic voltammogram of L-dopa (Figure 1 A) shows a profile that corresponds to an irreversible process with anodic and cathodic peak potentials at 677 mV and 300 mV, respectively. The voltammogram obtained for carbidopa (Figure 1 B) presented two irreversible oxidation waves with maximum currents registered at 677 mV and 1050 mV and a cathodic peak potential at 300 mV. This is an indicative of the presence of coupled chemical reactions as it was well discussed by Quintino et al.21 Zhang et al.17 attributes this second anodic peak to the oxidation of imine group of the carbidopa. Figure 1 C presents the cyclic voltammogram obtained for 1.25 ´ 10-3 mol L-1 L-dopa and 1.25 ´ 10-4 mol L-1 carbidopa in 0.1 mol L-1 perchloric acid solution using the MCPC with 20 %m/m PbO2. In this study different concentrations of L-dopa and carbidopa were utilized simulating those concentrations normally found in pharmaceutical formulations. As can be observed the same anodic and cathodic peaks were obtained, suggesting that the first anodic peak (677 mV) can be used for the determination of both compounds (L-dopa + carbidopa) and the second one at a potential of 1050 mV can be used for the determination of carbidopa. Figure 2 presents the cyclic voltammograms of 5.0 ´ 10-4 mol L-1 L-dopa in 0.1 mol L-1 HClO4 solution obtained with CPE (cyclic voltammogram a) and MCPE electrode (cyclic voltammogram b). The cyclic voltammogram shape of L-dopa or carbidopa (not shown) obtained using the CPE was in accordance with that obtained by Zhang et al.17 using a carbon disk electrode and with that obtained by Quintino et al.21 using a glassy carbon electrode in the same supporting solution. Nevertheless, as can be seen from this figure, using the MCPE containing 20% m/m PbO2 (10% m/m PbO2 + 10% m/m polyester resin) there is an increase of peak current (anodic and/or cathodic). The decreasing of the potential peaks (anodic or cathodic) observed for the L-dopa or carbidopa (not shown) for MCPE suggesting that an electrocatalytic process is occurring and/or absence of adsorption of those compounds in the MCPE surface area.
Electrode composition study
The effect of the lead oxide varying from 0 to 50% m/m and graphite powder from 75 to 25% m/m at fixed amount of solid paraffin of 25% m/m on the MCPE response for 1.0 ´ 10-4 mol L-1 L-dopa in 0.1 mol L-1 HClO4 was investigated. Figure 3 shows the dependence of peak potential (curve a) and peak current (curve b) as a function of the PbO2 content in the carbon paste using scan rate of 5.0 mV s-1, pulse amplitude of 50 mV and scan rate increment of 3 mV at 25.0 ± 0.2 °C. As it can be observed from this figure, the unmodified electrode (CPE; 0% /mm PbO2) presented a peak current of 6.0 µA and a peak potential of 708 mV and for a 20% m/m PbO2 composition a peak current of 12.1 µA and a peak potential of 677 mV were obtained. The results of lowered over-potential and increased current response are clear evidence of the catalytic effect and/or absence of adsorption of L-dopa. Similar results were obtained for carbidopa solution (results not shown). Therefore this electrode composition (20% m/m PbO2, 55% m/m graphite powder and 25% m/m solid paraffin) was selected for further studies.
Differential pulse voltammetry study and analytical curves
The differential pulse voltammetry (DPV) of 5.0 ´ 10-4 mol L-1 L-dopa and 8.0 ´ 10-5 mol L-1 carbidopa solutions in 0.1 mol L-1 HClO4 at DE varying from 10 to 80 mV were initially investigated. It has been noted that applied pulse amplitude has small influence on peak potentials. Nevertheless, the cathodic current peaks (ipc) obtained depend on of pulse amplitude applied to the working electrode (MCPE containing 20% m/m PbO2). It was found that the differential pulse voltammograms have better definitions using scan rate of 5.0 mVs-1, pulse amplitude of 50 mV and scan rate increment of 3 mV.
Under the optimum conditions established above, i.e. 0.1 mol L-1 HClO4 as supporting electrolyte, scan rate of 5.0 mVs-1, pulse amplitude of 50 mV and scan rate increment of 3 mV, the differential pulse voltammograms from 2.6 ´ 10-4 to 1.2 ´ 10-3 mol L-1 L-dopa and from 3.2 ´ 10-5 to 1.5 ´ 10-4 mol L-1 were obtained and are shown in Figure 4. The detection limits (three times the standard deviation of the base line/slope of the analytical curve) were 2.5 ´ 10-5 mol L-1 and 3.7 ´ 10-6 mol L-1 for L-dopa and carbidopa, respectively. The analytical curves obtained for L-dopa and carbidopa in those concentration ranges using the DPV technique, were Ipa = 0.4 + 8.0 ´ 104 [L-dopa] (r=0.9998) and Ipa = 0.2 + 2.5 ´ 104 [carbidopa] (r=0.9997), respectively where Ipa is the anodic peak currents, in µA [L-dopa] and [carbidopa] is the L-dopa and carbidopa concentration, respectively in mol L-1. Contrary to the conclusions of Zhang et al.,17 owing to the similar electrochemical behavior of L-dopa and carbidopa at a carbon disk electrode and consequent difficulty to determine these analytes simultaneously by using conventional voltammetry. In another work,21 carbidopa could be analyzed in the presence of L-dopa, however, it was verified that L-dopa shows some interferences. Such a problem was solved after to coat the glassy carbon electrode with a Nafion film, which was selective to carbidopa. In the present work, using a PbO2-modified electrode (MCPE) associated with differential pulse voltammetry technique, two well-defined peaks were obtained for L-dopa and carbidopa at potentials of 677 and 1050 mV, respectively, thus allowing the simultaneous determination of these catecholamines. The advantages of lead dioxide electrodes for high potential anodic processes as well discussed elsewere.23-25,30
Recovery, repeatability, interference studies and electrode lifetime
Recoveries varying from 98.1 to 104% of L-dopa and from 98.7 and 104% of carbidopa from two pharmaceutical products were obtained using the modified electrode. In this study, 41.7, 80.3 and 116.2 µg mL-1 of L-dopa and 7.40, 14.8 and 22.3 µg mL-1 of carbidopa were added to the sample solutions (n= 6) and the differential pulse voltammograms were obtained (Table 1). The recovery results obtained for Sinemet and Prolopa samples suggest an absence of matrix effects in these determinations.
The relative standard deviations (RSDs) were 1.0 and 2.5% for solutions containing 1.2 ´ 10-4 mol L-1 and 1.2 ´ 10-3 mol L-1 of L-dopa and carbidopa (n=10), respectively.
The effect of excipient substances frequently found with L-dopa and carbidopa in pharmaceutical formulations, such as sucrose, glucose, fructose, lactose, starch, poly(ethylene glycol), sodium chloride, magnesium stearate and indigo carmine, was evaluated using the proposed procedure. The ratios of the concentrations of L-dopa or carbidopa to those of excipient substances were fixed at 0.1, 1.0 and 10.0. None of these substances interfered in the DPV method.
The lifetime of the electrode was at least 15 months (over 1,500 determinations were performed for the carbon paste amount (ca. 0.170 g) used in the syringe), confirming the high stability of MCPE. By using PbO2 directly in the paste, the lifetime of the electrode was ca. 5-6 months (ca. 500 determinations).
The DPV procedure at the experimental conditions presented above was applied to the determination of L-dopa and carbidopa in pharmaceutical products. Table 2 shows the results obtained for two commercial samples using an enzymatic method4 and the proposed MCPE. Applying a paired-t test for the results obtained, it was found that all results are in agreement at the 95% confidence level and within an acceptable range of error.
The studies described on this paper shows that L-dopa and carbidopa can be simultaneously determined in pharmaceuticals by differential pulse voltammetry using a carbon paste electrode chemically modified with PbO2 immobilized in polyester resin. Additional advantages like simplicity, rapidity to prepare and low cost can be also reach. Moreover, the good results obtained, such as reproducibility, precision, accuracy and longer lifetime of MCPE suggest the proposed method is suitable for determination of those catecholamines and it can be used in routine control analysis.
The authors wish to thank CNPq, FAPESP and CAPES for their financial support.
1. Coomes, M. W.; In Biochemistry with Clinical Correlations, Devlin, T. M. ed.; Willey: New York, 1997. [ Links ]
2. Pudek, M. R.; In Methods in Clinical Chemistry, Kaplan, L. A; Pesce, A.J. eds., Mosby: St. Louis, MO, 1996. [ Links ]
3. Moffat, A.C.; Clarke's Isolation and Identification of Drugs, Pharmaceutical Press: London, 1986. [ Links ]
4. Fatibello-Filho, O.; Vieira, I.C.; Analyst 1997, 122, 345. [ Links ]
5. Issopoulos, P.B.; Fresenius J. Anal. Chem. 1990, 336, 124. [ Links ]
6. Steup, A.; Metzner, J.; Voll, A.; Pharmazie 1986, 41, 739. [ Links ]
7. Tolokan, A.; Klebovich, I.; BaloghNemes, K.; Horvai, G.; J. Chromatogr. B, 1997, 698, 201. [ Links ]
8. Kafil, J.B.; Dhingra, B.S.; J. Chromatogr. A 1994, 667, 175. [ Links ]
9. Rondelli, I.; Acerbi, D.; Mariotti, F.; Ventura, P.; J. Chromatogr. B 1994, 653, 17. [ Links ]
10. Deleu, D.; Sarre, S.; Ebinger, G.; Michotte, Y.; J. Pharm. Biomed. Anal. 1993, 11, 577. [ Links ]
11. Miller, R.B.; Dehelean, L.;Belanger, L.; Chromatographia 1993, 35, 607. [ Links ]
12. Wikberg, T.; J. Pharm. Biomed. Anal. 1991, 9, 167. [ Links ]
13. Lucarelli, C.; Betto, P.; Ricciarello, G.; Giambenedetti, M.; Corradini, C.; Stocchi, F.; Belliardo, F.; J. Chromatogr. A 1990, 511, 167. [ Links ]
14. Forster, I.; Junghanel, H.; Kropfgans, F.; Pharmazie 1998, 43, 47. [ Links ]
15. Michotte, Y.; Moors, M.; Deleu, D.; Herregodts, P.; Ebinger, G.; J. Pharm. Biomed. Anal. 1987, 5, 659. [ Links ]
16. Ha, P.T.T.; Van Schepdael, A.; Hauta-aho, T.; Roets, E.; Hoogmartens, J.; Electrophoresis 2002, 23, 3404. [ Links ]
17. Zhang, L.; Chen, G.; Hu, Q.; Fang, Y.Z.; Anal. Chim. Acta 2001, 431, 287. [ Links ]
18. Fanali, S.; Pucci, V.; Sabbioni, C.; Raggi, M.A.; Electrophoresis 2000, 21, 2432. [ Links ]
19. Sagar, K.A.; Smyth, M.R.; J. Pharm. Biomed. Anal. 2000, 22, 613. [ Links ]
20. Wang, J.; Zhou, Y.; Liang, J.; He, P.G.; Fang, Y.Z., Chromatographia 2005, 61, 265. [ Links ]
21. Quintino, M.S.M.; Yamashita, M.; Angnes, L.; Electroanalysis, 2006, 18, 655. [ Links ]
22. Fleet, B.; Fouzder, N.B. In Unit Processes In Organic Voltammetric Analysis II. Determination; Franklin W. S.; ed., Academic Press: London, 1979. [ Links ]
23. Borrás, C.; Rodríguez, P.; Laredo, T.; Mostany, J.; Scharifker, B. R.; J. Appl. Electrochem. 2004, 34, 583. [ Links ]
24. Popovic, N. D.; Jonson, D.C.; Anal. Chem. 1998, 70, 468. [ Links ]
25. Rodgers, J.D.; Jedral, W.; Bunce, N. J.; Environ. Sci. Technol. 1999, 33, 1453. [ Links ]
26. Teixeira, M. F. S.; Ramos, L. A.; Fatibello-Filho, O.; Cavalheiro, E. T. G.; Fresinius J. Anal. Chem. 2001, 370, 383. [ Links ]
27. Pereira, A.V.; Fatibello-Filho, O.; Talanta 1998, 47, 11. [ Links ]
28. Vieira, I.C.; Fatibello-Filho, O.; Talanta 2000, 52, 681. [ Links ]
29. Brett, C.M.A.; Brett, A.M.O.; Electroanalysis, Oxford University Press: New York, 1998. [ Links ]
30. Amadelli, R.; Velichenko, A. B.; J. Serb. Chem. Soc. 2001, 66, 835. [ Links ]
Received: November 3, 2006
Web Release Date: July 11, 2007
FAPESP helped in meeting the publication costs of this article.